Levuglandin

WikiDoc Resources for Levuglandin
Articles
Most recent articles on Levuglandin Most cited articles on Levuglandin Review articles on Levuglandin Articles on Levuglandin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Levuglandin Images of Levuglandin Photos of Levuglandin Podcasts & MP3s on Levuglandin Videos on Levuglandin
Evidence Based Medicine
Cochrane Collaboration on Levuglandin Bandolier on Levuglandin TRIP on Levuglandin
Clinical Trials
Ongoing Trials on Levuglandin at Clinical Trials.gov Trial results on Levuglandin Clinical Trials on Levuglandin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Levuglandin NICE Guidance on Levuglandin NHS PRODIGY Guidance FDA on Levuglandin CDC on Levuglandin
Books
Books on Levuglandin
News
Levuglandin in the news Be alerted to news on Levuglandin News trends on Levuglandin
Commentary
Blogs on Levuglandin
Definitions
Definitions of Levuglandin
Patient Resources / Community
Patient resources on Levuglandin Discussion groups on Levuglandin Patient Handouts on Levuglandin Directions to Hospitals Treating Levuglandin Risk calculators and risk factors for Levuglandin
Healthcare Provider Resources
Symptoms of Levuglandin Causes & Risk Factors for Levuglandin Diagnostic studies for Levuglandin Treatment of Levuglandin
Continuing Medical Education (CME)
CME Programs on Levuglandin
International
Levuglandin en Espanol Levuglandin en Francais
Business
Levuglandin in the Marketplace Patents on Levuglandin
Experimental / Informatics
List of terms related to Levuglandin

Levuglandins are reactive aldehydes formed by the spontaneous rearrangement of prostaglandin H (PGH). They are nonclassic eicosanoids. One species, levuglandin E₂, (LGE₂), forms neurotoxic adducts with amyloid beta.